Immunogen Shareholders Approve Merger with AbbVie Inc.
PremiumCompany AnnouncementsImmunogen Shareholders Approve Merger with AbbVie Inc.
9M ago
ImmunoGen’s Merger with AbbVie Awaits Shareholder Approval
Premium
Company Announcements
ImmunoGen’s Merger with AbbVie Awaits Shareholder Approval
10M ago
Immunogen Merges with AbbVie, Responds to Shareholder Complaints
Premium
Market News
Immunogen Merges with AbbVie, Responds to Shareholder Complaints
10M ago
ImmunoGen’s sBLA for Elahere in ovarian cancer granted priority review by FDA
PremiumThe FlyImmunoGen’s sBLA for Elahere in ovarian cancer granted priority review by FDA
11M ago
ImmunoGen downgraded to Neutral from Overweight at Piper Sandler
Premium
The Fly
ImmunoGen downgraded to Neutral from Overweight at Piper Sandler
11M ago
ImmunoGen downgraded to Equal Weight from Overweight at Barclays
Premium
The Fly
ImmunoGen downgraded to Equal Weight from Overweight at Barclays
11M ago
ImmunoGen downgraded to Market Perform from Outperform at BMO Capital
PremiumThe FlyImmunoGen downgraded to Market Perform from Outperform at BMO Capital
12M ago
ImmunoGen downgraded to Hold from Buy at Deutsche Bank
Premium
The Fly
ImmunoGen downgraded to Hold from Buy at Deutsche Bank
12M ago
ImmunoGen downgraded to Hold from Buy at Jefferies
Premium
The Fly
ImmunoGen downgraded to Hold from Buy at Jefferies
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100